Juslina DM 10mg/5mg/500mg Tablet

Juslina DM 10mg/5mg/500mg Tablet
Dapagliflozin (10mg) + Linagliptin (5mg) + Metformin (500mg)
Cheaper alternative availability
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
About This Medicine
Product description & overview
Juslina DM 10mg/5mg/500mg Tablet is a fixed-dose combination medication containing Dapagliflozin 10mg, Linagliptin 5mg, and Metformin 500mg, indicated for the management of type 2 diabetes mellitus. This combination targets multiple pathophysiological defects of diabetes to improve glycemic control. Dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, promotes renal glucose excretion, thereby reducing plasma glucose levels. Linagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, enhances incretin hormone activity, increasing insulin secretion and decreasing glucagon release in a glucose-dependent manner. Metformin, a biguanide, primarily decreases hepatic glucose production and improves peripheral insulin sensitivity. The synergistic action of these agents offers effective glycemic control with a reduced risk of hypoglycemia. Juslina DM is typically prescribed as an adjunct to diet and exercise in patients inadequately controlled on monotherapy or dual therapy. It is contraindicated in patients with severe renal impairment, metabolic acidosis, or hypersensitivity to any component. Common adverse effects may include gastrointestinal disturbances, urinary tract infections, and potential risk of lactic acidosis. Regular monitoring of renal function, blood glucose, and HbA1c is recommended during therapy. Juslina DM should be used under medical supervision with appropriate lifestyle modifications for optimal diabetes management.
Active composition
Dapagliflozin 10 mg
+2 more active ingredients
All Active Ingredients
Metformin
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Linagliptin
Linagliptin inhibits the enzyme DPP-4, leading to increased levels of incretin hormones, which promote insulin secretion and inhibit glucagon release, thereby lowering blood glucose levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
It is not known whether it is safe to consume alcohol with Juslina DM 10mg/5mg/500mg Tablet. Please consult your doctor.
High Risk
Pregnancy
Information regarding the use of Juslina DM 10mg/5mg/500mg Tablet during pregnancy is not available. Please consult your doctor.
Medical Advice
Driving
Juslina DM 10mg/5mg/500mg Tablet does not usually affect your ability to drive.
Exercise Caution
Liver
There is limited information available on the use of Juslina DM 10mg/5mg/500mg Tablet in patients with liver disease. Please consult your doctor.
Regular Checkup
Breastfeeding
Information regarding the use of Juslina DM 10mg/5mg/500mg Tablet during breastfeeding is not available. Please consult your doctor.
Consult Doctor
Kidney
There is limited information available on the use of Juslina DM 10mg/5mg/500mg Tablet in patients with kidney disease. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Juslina DM 10mg/5mg/500mg Tablet







